Stockscreener 앱 받기
1.2039
0.84%
0.0139
Opko Health Inc 주식(OPK)의 최신 뉴스
OPK5733212 Bond Coupon Profile — Rate & Payments - TradingView
OPKO Health Inc (OPK) Institutional Confidence - TradingKey
OPK5733212 Bond Profile — Key Metrics - TradingView
OPK.O| Stock Price & Latest News - Reuters
Zacks Research Has Weak Estimate for OPKO Health Q2 Earnings - MarketBeat
ETFs Investing in OPKO Health, Inc. Stocks - TradingView
Here's why you should retain OPK stock in your portfolio for now - MSN
OPKOpko Health Inc Options - Finviz
OPKO Health Inc focuses on diagnostics and pharmaceuticals as investors weigh long-term prospects - ad-hoc-news.de
Form 13D/A OPKO HEALTH For: 1 July By Investing.com - Investing.com UK
OPKO Health (OPK) Piper Sandler 36th Annual Healthcare Conference Summary - Quartr
Phillip Frost (NASDAQ: OPK) reports 34.1% beneficial stake in OPKO - Stock Titan
OPKO Health (OPK) up 17.1% since last earnings report: Can it continue? - MSN
XCY Forecast — Price Target — Prediction for 2027 - TradingView
OPKO Health, Inc. Actuals & Estimates (BMV:OPK) - TradingView
Price to sales forward of Opko Health, Inc. – NASDAQ:OPK - TradingView
Opko Health stock hits 52-week high at 1.6 USD By Investing.com - Investing.com South Africa
Enterprise value to EBITDA forward of Opko Health, Inc. – NASDAQ:OPK - TradingView
Price to book forward of OPKO Health, Inc. – FWB:XCY - TradingView
Price to earnings forward of OPKO Health, Inc. – FWB:XCY - TradingView
Enterprise value to EBIT forward of Opko Health, Inc. – NASDAQ:OPK - TradingView
Enterprise value to EBIT forward of OPKO Health, Inc. – FWB:XCY - TradingView
OPKO Health, Inc. Actuals & Estimates (NASDAQ:OPK) - TradingView
OPKO Health, Inc. Actuals & Estimates (BX:XCY) - TradingView
OPKO Health, Inc. Actuals & Estimates (FWB:XCY) - TradingView
OPKO Health, Inc. Actuals & Estimates (TASE:OPK) - TradingView
OPK Forecast — Price Target — Prediction for 2027 - TradingView
OPKO Health (OPK) Stock Could Be 57% Undervalued As Margin Recovery Comes Into Focus - Sahm
OPKO Health (OPK) Hovers Near Key Resistance Amid Modest GainsRisk Reward Setups - DonanımHaber
OPKO Health (OPK) Edges Higher as Stock Nears Key Support LevelAAII Bullish - DonanımHaber
Form 4 Opko Health For: 22 June By Investing.com - Investing.com Nigeria
Director at OPKO (NASDAQ: OPK) receives grant of 60,000 stock options - Stock Titan
OPKO Health (OPK) director receives 30,000-share stock option award at $1.42 - Stock Titan
Opko Health (OPK) director Roger Medel receives 30,000 stock options grant - Stock Titan
Opko Health (OPK) director awarded 30,000 stock options at $1.42 strike - Stock Titan
OPKO Health (OPK) director receives stock options for 30,000 shares - Stock Titan
OPKO HEALTH (OPK) director receives 80,000-share stock option grant - Stock Titan
Opko Health Shareholders Back Board, Equity and Auditors - The Globe and Mail
Opko Health shareholders elect board and approve key proposals at annual meeting - Investing.com
OPKO Health (OPK) AGM 2026 Summary - Quartr
OPK: All proposals passed, with robust pipeline progress and $98M remaining for share repurchases - TradingView
OPKO Health Inc (OPK) Valuation: PE, PB & Fair Value Analysis - TradingKey
OPK: All proposals passed; clinical pipeline and cash flow strong; $98M buyback authorization remains - TradingView
OPKO Health Inc (OPK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OPKO Health Inc (OPK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
OPKO Health Inc (OPK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OPKO Health Inc (OPK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OPKO Health Inc (OPK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OPKO Health Inc (OPK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
OPKO Health Inc (OPK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Piper Sandler Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3 - Moomoo
Piper Sandler Sticks to Their Buy Rating for Opko Health (OPK) - The Globe and Mail
0.21%
2.05%
자본화:
|
볼륨(24시간):